首页|合并2型糖尿病的亚临床甲状腺功能减退症人群骨质疏松相关生物标志物水平分析

合并2型糖尿病的亚临床甲状腺功能减退症人群骨质疏松相关生物标志物水平分析

扫码查看
目的 探讨合并2型糖尿病的亚临床甲状腺功能减退症(亚甲减)人群骨质疏松相关生物标志物水平.方法 本研究属于横断面研究,选择2021年1月至2022年6月就诊于山西白求恩医院的亚甲减患者、2型糖尿病患者、2型糖尿病合并亚甲减患者、同期健康体检人群各40例,检测受试者糖脂代谢指标及骨代谢指标,采用t检验、非参数检验及相关性分析比较各组间代谢指标的差异以及分析指标间的相关性.结果 与健康组相比,2型糖尿病组Ⅰ型胶原羧基端肽β特殊序列(β-CTX)水平较高[(344.60±125.61)比(227.56±68.33)pg/ml](t=-5.176,P<0.001),骨钙素(OC)和总 Ⅰ 型胶原氨基端延长肽(t-PINP)较低[(15.76±4.70)比(28.02±5.83)ng/ml、(43.49±13.63)比(59.58±15.80)ng/ml](t=10.352,4.874,均P<0.001),2型糖尿病合并亚甲减患者的β-CTX水平较单纯亚甲减患者高[(380.51±122.22)比(212.41±44.17)pg/ml](t=-8.180,P<0.001),OC 和 t-PINP 较低[(13.67±4.06)比(26.12±4.55)ng/ml、(38.76±9.53)比(61.50±12.31)ng/ml](t=12.897,4.356,均 P<0.001),但与单纯 2 型糖尿病患者相比,3项指标差异均无统计学意义[(380.51±122.22)比(344.60±125.61)pg/ml、(13.67± 4.06)比(15.76±4.70)ng/ml、(38.76±9.53)比(43.49±13.63)ng/ml](t=1.296,1.890,-1.799,均 P>0.05).在2型糖尿病合并亚甲减患者中β-CTX与空腹血糖、糖化血红蛋白均呈正相关(r=0.293,0.487,均P<0.05),而OC和t-PINP与空腹血糖、糖化血红蛋白均呈负相关(r=-0.560,-0.502,-0.289,-0.326,均P<0.05).结论 合并2型糖尿病的亚甲减人群骨质疏松相关生物标志物水平发生改变,提示其骨松风险增加.
Analysis of osteoporosis-related biomarker levels in patients with subclinical hypothyroidism complicated with type 2 diabetes mellitus
Objective To investigate the levels of osteoporosis-related biomarkers in individuals with subclinical hypothyroidism complicated by type 2 diabetes mellitus.Methods A cross-sectional study.From January 2021 to June 2022,40 patients with subclinical hypothyroidism,40 patients with type 2 diabetes,40 patients with type 2 diabetes complicated with subclinical hypothyroidism,and 40 individuals receiving physical examination in Shanxi Bethune Hospital were selected as subjects in this study.The glucose and lipid metabolism indexes and bone metabolism indexes of the subjects were detected,and the differences and correlations of the metabolic indexes among the groups were analyzed by t-tests,nonparametric tests or correlation analysis.Results Compared with healthy group,beta C-terminal cross-linked telopeptides of type Ⅰ collagen(β-CTX)level in type 2 diabetes group was higher[(344.60±125.61)vs(227.56±68.33)pg/ml](t=-5.176,P<0.001),osteocalcin(OC)and total procollagen type 1 aminoterminal peptide(t-PINP)were both lower[(15.76±4.70)vs(28.02±5.83)ng/ml,(43.49±13.63)vs(59.58±15.80)ng/ml](t=10.352,t=4.874,P<0.001).The β-CTX level in type 2 diabetes patients complicated with hypothyroidism was higher than that in patients with simple subclinical hypothyroidism[(380.51±122.22)vs(212.41± 44.17)pg/ml](t=-8.180,P<0.001),but the levels of OC and t-PINP were both lower[(13.67±4.06)vs(26.12±4.55)ng/ml,(38.76±9.53)vs(61.50±12.31)ng/ml](t=12.897,P<0.001);but there was no significant difference in the three biomarkers between patients with type 2 diabetes mellitus complicated by subclinical hypothyroidism and those with type 2 diabetes mellitus alone.[β-CTX:(380.51±122.22)vs(344.60±125.61)pg/ml,OC:(13.67±4.06)vs(15.76±4.70)ng/ml,t-PINP:(38.76±9.53)vs(43.49±13.63)ng/ml](t=1.296,1.890,-1.799,all P>0.05).In the patients with type 2 diabetes mellitus complicated by subclinical hypothyroidism,the β-CTX was positively correlated with fasting blood glucose(FBG)and glycosylated hemoglobin(HbA1c)(r=0.293,0.487,all P<0.05),while OC and t-PINP were negatively correlated with FBG and HbA1c(r=-0.560,-0.502,-0.289,-0.326,P<0.05).Conclusion Changes of serum osteoporosis-related biomarkers in subclinical hypothyroidism patients with type 2 diabetes indicate the increased risk of osteoporosis in those patients.

Subclinical hypothyroidismDiabetes mellitusOsteoporosis

郑洁、段瑞雪、赵宇翔、李欣、陈晓琴、刘师伟

展开 >

山西白求恩医院(山西医学科学院同济山西医院),山西医科大学第三医院内分泌代谢病山西省重点实验室,太原 030032

亚临床甲状腺功能减退症 糖尿病 骨质疏松

山西省基础研究计划山西省科技创新人才团队专项计划内分泌代谢病山西省重点实验室

20210302123487202204051002029202104010910009

2024

中华健康管理学杂志
中华医学会

中华健康管理学杂志

CSTPCD北大核心
影响因子:1.004
ISSN:1674-0815
年,卷(期):2024.18(4)
  • 20